These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 25108207

  • 1. Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide.
    Choe JY, Kim SK.
    Clin Chim Acta; 2015 Jan 01; 438():29-34. PubMed ID: 25108207
    [Abstract] [Full Text] [Related]

  • 2. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C, Chen S, Gu Y, Lao Z, Ni L, Yu Q, Xu J, Li X, Liu J, Sun L, He P, Ma J, Xu S, Ding C.
    Chin Med J (Engl); 2003 Aug 01; 116(8):1228-34. PubMed ID: 12935395
    [Abstract] [Full Text] [Related]

  • 3. Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis.
    Costa NT, Scavuzzi BM, Iriyoda TMV, Lozovoy MAB, Alfieri DF, de Medeiros FA, de Sá MC, Micheletti PL, Sekiguchi BA, Reiche EMV, Maes M, Simão ANC, Dichi I.
    Clin Exp Med; 2018 Aug 01; 18(3):363-372. PubMed ID: 29644482
    [Abstract] [Full Text] [Related]

  • 4. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA, Stamp LK, O'Donnell JL, Savage RL, Chapman PT.
    J Rheumatol; 2007 Nov 01; 34(11):2201-3. PubMed ID: 17937473
    [Abstract] [Full Text] [Related]

  • 5. The hypouricemiant effect of leflunomide.
    Arida D, Silva L, Skare TL.
    Joint Bone Spine; 2014 May 01; 81(3):273-4. PubMed ID: 24289959
    [No Abstract] [Full Text] [Related]

  • 6. Leflunomide and methotrexate reduce levels of activated matrix metalloproteinases in complexes with alpha2 macroglobulin in serum of rheumatoid arthritis patients.
    Tchetverikov I, Kraan MC, van El B, Hanemaaijer R, DeGroot J, Huizinga TW.
    Ann Rheum Dis; 2008 Jan 01; 67(1):128-30. PubMed ID: 17875551
    [Abstract] [Full Text] [Related]

  • 7. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep 01; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 8. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis.
    Rodriguez-Rodriguez L, Jover-Jover JA, Fontsere O, Peña-Blanco RC, León L, Fernández-Gutierrez B, Abásolo L.
    Scand J Rheumatol; 2013 Sep 01; 42(6):433-6. PubMed ID: 23742043
    [Abstract] [Full Text] [Related]

  • 9. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM.
    Clin Ther; 1999 Nov 01; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [Abstract] [Full Text] [Related]

  • 10. The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis.
    Klimiuk PA, Kita J, Chwiecko J, Sierakowski S.
    Clin Rheumatol; 2009 Jan 01; 28(1):17-21. PubMed ID: 18663553
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis.
    Kullich WC, Mur E, Aglas F, Niksic F, Czerwenka C.
    Clin Exp Rheumatol; 2006 Jan 01; 24(2):155-60. PubMed ID: 16762150
    [Abstract] [Full Text] [Related]

  • 12. Effects of double filtration plasmapheresis, leflunomide, and methotrexate on inflammatory changes found through magnetic resonance imaging in early rheumatoid arthritis.
    Yu X, Wang L, Xu P, Lu W, Lan G, Ping L, Wang X, Tian J, Liu J.
    J Rheumatol; 2012 Jun 01; 39(6):1171-8. PubMed ID: 22505700
    [Abstract] [Full Text] [Related]

  • 13. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.
    Arthritis Rheum; 2005 Oct 01; 52(10):3030-8. PubMed ID: 16200612
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rheumatoid arthritis, alcohol, leflunomide and methotrexate. Can changes to the BSR guidelines for leflunomide and methotrexate on alcohol consumption be justified?
    Rajakulendran S, Gadsby K, Deighton C.
    Musculoskeletal Care; 2008 Dec 01; 6(4):233-45. PubMed ID: 18702106
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G.
    J Rheumatol; 2013 Mar 01; 40(3):228-35. PubMed ID: 23322457
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J, Díaz-Torné C, Ruiz JM, Hernández MV, Torrente-Segarra V, Ros S, Rodriguez de la Serna A, Díaz-López C, Sanmartí R, Nolla JM.
    Semin Arthritis Rheum; 2011 Dec 01; 41(3):401-5. PubMed ID: 21862107
    [Abstract] [Full Text] [Related]

  • 20. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M, Creemers MC, Welsing PM, van Riel PL.
    Rheumatology (Oxford); 2005 Apr 01; 44(4):472-8. PubMed ID: 15598707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.